Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?

被引:5
作者
De Kesel, Pieter M. M. [1 ]
Lambert, Willy E. [1 ]
Stove, Christophe P. [1 ]
机构
[1] Univ Ghent, Fac Pharmaceut Sci, Dept Bioanal, Toxicol Lab, B-9000 Ghent, Belgium
关键词
CYP1A2; ACTIVITY; PREGNANT-WOMEN; CAFFEINE; DRUG; METABOLISM; SALIVA;
D O I
10.1007/s40262-015-0237-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Objective Although metabolite-to-parent drug concentration ratios in hair have been suggested as a possible tool to study the metabolism of drugs in a non-invasive way, no studies are available that evaluated this in a systematic way. Cytochrome P450 (CYP) 1A2 is a drug-metabolizing enzyme characterized by large inter-individual differences in its activity. The standard approach for CYP1A2 phenotyping is to determine the paraxanthine/caffeine ratio in plasma at a fixed timepoint after intake of a dose of the CYP1A2 substrate caffeine. The aim of this study was to evaluate whether paraxanthine/caffeine ratios measured in hair samples reflect the plasma-based CYP1A2 phenotype. Methods Caffeine and paraxanthine concentrations were measured in proximal 3 cm segments of hair samples from 60 healthy volunteers and resulting paraxanthine/caffeine ratios were correlated with CYP1A2 phenotyping indices in plasma. Results Paraxanthine/caffeine ratios in hair ranged from 0.12 to 0.93 (median 0.41); corresponding ratios in plasma ranged from 0.09 to 0.95 (median 0.40). A statistically significant correlation was found between ratios in hair and plasma (r = 0.41, p = 0.0011). However, large deviations between ratios in both matrices were found in individual cases. Although the influence of several factors on paraxanthine/caffeine ratios and hair-plasma deviations was investigated, no evident factors explaining the observed variability could be identified. Conclusion The variability between hair and plasma ratios complicates the interpretation of hair paraxanthine/caffeine ratios on an individual basis and, therefore, compromises their practical usefulness as alternative CYP1A2 phenotyping matrix.
引用
收藏
页码:771 / 781
页数:11
相关论文
共 35 条
  • [1] Guidelines for European workplace drug and alcohol testing in hair
    Agius, Ronald
    Kintz, Pascal
    [J]. DRUG TESTING AND ANALYSIS, 2010, 2 (7-8) : 367 - 376
  • [2] Barbosa J, 2013, BIOANALYSIS, V5, P895, DOI [10.4155/BIO.13.50, 10.4155/bio.13.50]
  • [3] Pharmacogenomics in Psychiatry: From Therapeutic Drug Monitoring to Genomic Medicine
    Crettol, S.
    de Leon, J.
    Hiemke, C.
    Eap, C. B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (03) : 254 - 257
  • [4] CYP1A2 phenotyping in dried blood spots and microvolumes of whole blood and plasma
    De Kesel, Pieter M. M.
    Lambert, Willy E.
    Stove, Christophe P.
    [J]. BIOANALYSIS, 2014, 6 (22) : 3011 - 3024
  • [5] Why Dried Blood Spots Are an Ideal Tool for CYP1A2 Phenotyping
    De Kesel, Pieter M. M.
    Lambert, Willy E.
    Stove, Christophe P.
    [J]. CLINICAL PHARMACOKINETICS, 2014, 53 (08) : 763 - 771
  • [6] De Kesel PM, LONDON FUTU IN PRESS
  • [7] Is one hair lock really representative?
    Dussy, Franz
    Carson, Nicholas
    Hangartner, Sarah
    Briellmann, Thomas
    [J]. DRUG TESTING AND ANALYSIS, 2014, 6 : 5 - 8
  • [8] Eisenhut Michael, 2012, Tuberc Res Treat, V2012, P327027, DOI 10.1155/2012/327027
  • [9] European Medicines Agency, Guidelines on Bioanalytical Method Validation
  • [10] Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach
    Fuhr, U.
    Jetter, A.
    Kirchheiner, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 270 - 283